The olfactory bulb is a source of high-frequency oscillations (130–180 Hz) associated with a subanesthetic dose of ketamine in rodents by Hunt, Mark Jeremy et al.
This is a repository copy of The olfactory bulb is a source of high-frequency oscillations 
(130–180 Hz) associated with a subanesthetic dose of ketamine in rodents.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/136153/
Version: Published Version
Article:
Hunt, Mark Jeremy, Adams, Natalie Elizabeth, Sredniawa, Wladyslaw et al. (4 more 
authors) (2018) The olfactory bulb is a source of high-frequency oscillations (130–180 Hz) 
associated with a subanesthetic dose of ketamine in rodents. Neuropsychopharmacology. 
ISSN 0893-133X 
https://doi.org/10.1038/s41386-018-0173-y
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
ARTICLE OPEN
The olfactory bulb is a source of high-frequency oscillations
(130–180 Hz) associated with a subanesthetic dose of ketamine
in rodents
Mark Jeremy Hunt1,2, Natalie E Adams1, Władysław Średniawa 2,3, Daniel K Wójcik2, Anna Simon1, Stefan Kasicki2 and
Miles Adrian Whittington1
High-frequency neuronal population oscillations (HFO, 130–180 Hz) are robustly potentiated by subanesthetic doses of ketamine.
This frequency band has been recorded in functionally and neuroanatomically diverse cortical and subcortical regions, notably
ventral striatal areas. However, the locus of generation remains largely unknown. There is compelling evidence that olfactory
regions can drive oscillations in distant areas. Here we tested the hypothesis that the olfactory bulb (OB) is a locus for the
generation of HFO following a subanesthetic dose of ketamine. The effect of ketamine on the electrophysiological activity of the OB
and ventral striatum of male Wistar rats was examined using ﬁeld potential and unit recordings, local inhibition, naris blockade,
current source density and causality estimates. Ketamine-HFO was of larger magnitude and was phase-advanced in the OB relative
to ventral striatum. Granger causality analysis was consistent with the OB as the source of HFO. Unilateral local inhibition of the OB
and naris blockade both attenuated HFO recorded locally and in the ventral striatum. Within the OB, current source density analysis
revealed HFO current dipoles close to the mitral layer and unit ﬁring of mitral/tufted cells was phase locked to HFO. Our results
reveal the OB as a source of ketamine-HFO which can contribute to HFO in the ventral striatum, known to project diffusely to many
other brain regions. These ﬁndings provide a new conceptual understanding on how changes in olfactory system function may
have implications for neurological disorders involving NMDA receptor dysfunction such as schizophrenia and depression.
Neuropsychopharmacology (2018) 0:1–8; https://doi.org/10.1038/s41386-018-0173-y
INTRODUCTION
Ketamine is a non-competitive NMDA antagonist that is used
widely to model acute psychoses in humans and experimental
animals [1] and more recently to treat depression [2]. NMDAR
antagonists can affect neuronal oscillations, including gamma and
delta rhythms, both associated with schizophrenia and depression
[3–5]. In rodents, a prominent feature observed after subanes-
thetic injection of ketamine, and related NMDAR antagonists, are
high-frequency oscillations (HFO, 130–180 Hz) in ﬁeld potential
recordings from the ventral striatum (VS), caudate, hippocampus,
diverse cortical and brainstem regions [6–10]. There is evidence
that VS subregions are involved, at least in part, in ketamine-HFO
generation [11], however, to date, the origin of this widespread
oscillation remains unclear.
Elevated HFO has also been reported in serotonergic [12] and
neurodevelopmental rodent models of schizophrenia [10, 13] but
it is unclear if this rhythm is altered in patients. Certainly, the HFO-
frequency range overlaps with what some researchers call ‘high-
gamma’ rhythms which are implicated widely in sensory proces-
sing in humans [14]. In rodents, HFO as part of physiological
hippocampal sharp waves, are well known to mediate memory
consolidation [15], indicating abnormal HFO rhythms may
inﬂuence fundamental cognitive processes.
Oscillatory activity in olfactory systems, in particular the
olfactory bulb (OB), can potently drive coherent rhythmic
activity in anatomically distant brain areas [16, 17]. One of
these putative target areas is the VS, which, in turn, is reciprocally
connected to many brain regions involved in emotion and
motivation [18]. Although not widely associated with psychiatric
disease, disturbances in olfactory function can be the earliest
symptoms manifest in patients with schizophrenia, often
occurring during the preceding at-risk phase [19]. Olfactory
dysfunction is also becoming increasingly recognised as
a prodromal marker for neurodegenerative disorders [20].
Additionally, in rodents, primary disruption of olfactory processing
leads to behaviours that are unrelated to olfactory deﬁcits
involving cortico-limbic networks [21]. A high-frequency rhythm
(100–130 Hz) in the rodent OB has been reported under
ketamine–xylazine anaesthesia indicating OB circuitry can
generate fast rhythms [22]. The need to clearly identify
unambiguous sources of ketamine-HFO, and the limited number
of studies investigating how ketamine inﬂuences olfactory
networks, prompted us to investigate the effect of ketamine
on LFP oscillations in the OB and their possible impact on the
nucleus accumbens (NAc) subregion of the VS.
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MATERIALS AND METHODS
Surgery and recording
Twenty male Wistar rats (250–350 g) were used in this study.
In nine rats, tungsten electrodes (125 µm, Science Products,
Germany) were implanted bilaterally in OB (AP+ 7.5, ML= ±0.5,
DV= 3–3.5 mm) and in the right VS (AP=+1.6, ML=+0.8,
DV= 7mm) [23]. In seven rats, 22 gauge stainless steel guides
(Bilaney, Germany) and electrodes were implanted bilaterally
in the OB and electrodes bilaterally in the VS. In four rats a
microdrive-mounted 32-channel silicon probe (Edge-10 mm-
20-177-H32_21mm, Neuronexus, USA), interelectrode distance
20 µm, was implanted in the right OB. A screw posterior to the
bregma was used as a reference/ground.
One week after surgery, rats were placed in an arena
(50×50×50 cm) and local ﬁeld potentials (LFPs) recorded before
and after 25mg/kg ketamine injection (i.p). LFP’s were ampliﬁed
×1000, ﬁltered 0.01–1000 Hz and digitised at 1.6 kHz (AlphaLab,
AlphaOmega, Israel). A number of other studies have examined
the effect of other doses of ketamine (e.g. 10–60mg/kg, [24]) on
LFP oscillations in other frequency bands in rodents (<90 Hz),
however we, and others have found that 25mg/kg produces the
most robust increase in HFO power [8]. Intraperitoneal saline
injection was used as a control for systemic ketamine injection in 6
rats. Infusions: 0.5 µg muscimol (0.5 µl/1-min) was infused (28
gauge needle, Bilaney, Germany) to one OB and saline to the other
side. Rats were reconnected and 25mg/kg ketamine injected (i.p)
immediately. At least 72 h later the experiments were repeated
with muscimol/saline-infused sides reversed. Naris blockade:
These experiments were carried out during the recovery phase
of ketamine anaesthesia 200 mg/kg. During recovery, rats are
manageable, and naris blockade can be achieved in a straightfor-
ward manner. Importantly, during recovery HFO is visible in LFP
spectra from VS [8] and OB (Supplementary Figure 2 and Fig. 3). A
cotton bud was used to press a soft rubber base to close one naris
(at least 60 s). This procedure was repeated for the opposite naris.
Rats for this study were also used in the systemic ketamine study.
Multi-unit activity (MUA): Rats chronically implanted with silicon
32-channel probes which were gradually advanced over several
recording days until they reached a depth of around 3–4mm or
phase reversal was visible. Wideband signals were recorded from
freely moving rats (DC-11 kHz, sampled at 44 kHz). Recordings
were made before and after injection of ketamine 25mg/kg
at different depths with 3–4 days separating each recording
session. Electrode locations were determined on 40 µm Cresyl
violet (Sigma, UK) or Hoechst (Sigma, UK) stained sections. All
experiments were conducted in accordance with the European
community guidelines on the Care and Use of Laboratory Animals
(86/609/EEC) and approved by a local ethics committee.
Analysis
Mean power spectra of the LFP were carried out on successive 60-
s data blocks using a fast Fourier transform (4096 points) and the
dominant power of HFO (130–180 Hz) calculated (Spike 2, CED,
UK). Granger causality was computed over a series of orders (1–10)
for 1–350 Hz. LFPs were split into 500 ms sections overlapped by
10ms to create trials over which results were averaged, using a 50
ms window with one_bi_ga.m from the BSMART toolbox (SHIS UT-
Houston, USA), MATLAB. Coherence spectra (2048 points) were
computed for OB and VS, using the raw LFP, for 60 s before and
after ketamine injection. Waveform correlation between the
signals was computed using the 130–180 Hz band-pass ﬁltered
signal over 60 s. Current source density (CSD) analysis of the
130–180 Hz ﬁltered signal was performed with the kernel CSD
method [25]. Average CSD’s for each rat were triggered on
troughs of HFO in the most dorsal electrode. Phase differences
were calculated for the 130–180 Hz ﬁltered signal with respect
to the most dorsal contact (where HFO has large amplitude).
MUA was extracted using a threshold of 1.5 or 3 SD of the 500 Hz
high-pass Butterworth third order ﬁltered signal. Negative peaks
of spikes were marked as events. HFO troughs of the most
dorsal contact were used to trigger MUA (non-overlapping 50ms
sweeps).
Statistical analysis
Unless stated otherwise, data were analysed using repeated-
measures ANOVA followed by the Bonferroni post hoc test.
p < 0.05 were considered statistically signiﬁcant.
RESULTS
The OB leads ketamine-HFO in ventral striatal areas
Intraperitoneal injection of 25mg/kg ketamine produced almost
immediate overt behavioural activation (characterised by hyper-
locomotion, ‘circling’ and rearing) of 10–15min duration which
correlates with increases in the power of HFO [8]. Figure 1 shows
the effect of intraperitoneal 25 mg/kg ketamine administration on
the power of HFO recorded in the OB and VS. Increased HFO
power lasted around 15min after which time the power gradually
returned to baseline values. As can be seen in the representative
spectrogram, shown in Fig. 1a, ketamine mainly increased power
in the HFO band, though changes in other frequency bands
were evident (see below). Quantitative comparison of the group
means revealed that HFO power was signiﬁcantly larger in the
OB compared to the VS, both at baseline and after injection
of ketamine (brain region × time F64,1024= 9.82, p < 0.0001)
(Fig. 1b). This ﬁnding was particularly striking, since previous
reports have shown the power of HFO in the VS to be larger than
in other areas (e.g. dorsal striatum, hippocampus, visual and
cortical areas) [6, 11, 26]. Minute-by-minute analysis post ketamine
injection revealed a positive correlation (p < 0.0001, n= 9)
between the power of HFO in the OB and VS (R2 range
0.93–0.98, Fig. 1c). Systemic injection of saline did not inﬂuence
the power of HFO recorded in the OB (F39,234= 0.032, p= 1.0,
one-way ANOVA, see Supplementary 1, n= 6 rats).
Coherence, an index of frequency coupling between simulta-
neously recorded LFP’s, showed a clear increase at the HFO band
and was signiﬁcantly different between the ketamine and baseline
conditions in the 141–163 Hz range (p < 0.001, Bonferroni test)
(Fig. 1d). Generally, coherence at other frequencies was not
different after ketamine injection although a signiﬁcant reduction
in coherence was observed around 2 Hz, delta frequency
(p < 0.001).
To more precisely examine any relationship of HFO events
recorded in the OB and VS, the LFP signal was band-pass ﬁltered
at 130–180 Hz. At the macroscopic level bursts of HFO in the OB
and VS shared almost identical temporal dynamics (Fig. 1e).
However, closer inspection of the ﬁltered signal revealed that HFO
recorded in the OB preceded the activity recorded in the VS for
multiple cycles (Fig. 1f). Global waveform correlation between the
OB and VS revealed a strong correlation with a delay of around
0.45 ± 0.16 ms in the VS (Fig. 1g). This apparent unidirectional
relationship between HFO in OB and VS was analysed further:
Granger causality estimates can be used to determine the
magnitude and direction of the temporal relationship between
simultaneously recorded LFPs. The unﬁltered LFP Granger
causality spectra revealed a strong causality score for the HFO
band in the OB→ VS direction. In contrast, there was no causality
score, above baseline for the HFO band in the VS→OB direction
(Fig. 1h, i). Mean difference plots highlighted this HFO-speciﬁc,
unidirectional pattern of causality in a signiﬁcant manner (Fig. 1j).
Normal OB function is required for ketamine-induced HFO in the
ventral striatum
To investigate whether OB activity inﬂuences HFO recorded in the
VS, we implanted rats (n= 7) bilaterally with a guide/electrode
complex in the OB and recording electrodes in the VS. Within
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animal design experiments were carried out for each rat, so that
muscimol was infused to the left or right OB on different
experimental days. Saline was infused to the contralateral OB as a
control and the mean of both experiments/rat were calculated.
Representative spectrograms of the time-course of ketamine-HFO
in the OB and VS are shown in Fig. 2a, d, respectively. The
130–180 Hz band-pass ﬁltered and raw LFP waveforms post
ketamine for the OB and VS are shown in Fig. 2b, e, respectively.
Large-amplitude HFO was visible in the saline-infused ‘control’
side, whereas muscimol infusion almost completely attenuated
HFO. Group analyses revealed that unilateral infusion of 0.5 µg
muscimol to the OB led to a dramatic and almost immediate
reduction of ketamine-HFO power in both the OB and VS on the
ipsilateral side (muscimol × time F56,672= 5.24, p < 0.0001)
(Fig. 2c, f). In contrast, increases in HFO power were observed
on the saline-infused side. This effect was robust and consistent
Fig. 1 Ketamine-enhanced HFO in the OB precedes the VS. a LFP spectrograms of simultaneous recordings in the OB and VS showing
the effect of intraperitoneal injection of 25 mg/kg ketamine. Note the strong power of HFO (close to 150 Hz) immediately after injection
of ketamine. The same scale is used for both plots. b Time-course showing mean ± SEM HFO power in the OB (white circles) and VS
(black triangles) before and after injection of ketamine (n= 9 rats). The power of HFO was signiﬁcantly larger in the OB. c Correlation of HFO
power in the OB and VS was highly signiﬁcant for all rats (each data point represents an individual rat). The mean ± SEM is also shown.
d Ketamine injection was associated with an increase in the mean coherence between the OB and VS, which was prominent at the HFO band.
e 130–180 Hz band-pass ﬁltered signal (top pair) and the raw LFP (bottom pair) recorded simultaneously from the OB and VS shortly after
injection of ketamine. Bursts of HFO are clearly visible in recordings from both sites. f Expansion of a single HFO burst showing that HFO
recorded in the OB precedes the VS. Dotted lines indicate the troughs of HFO in the OB. g Mean waveform correlation for the 130–180 Hz
band-pass ﬁltered signal in the VS relative to the OB. Zero is the peak of the OB HFO waveform showing HFO occurs relatively later in the VS.
h, i Mean Granger causality relationship for the OB→ VS and VS→OB direction, respectively. j Mean difference between the Granger analyses
the contoured areas indicate signiﬁcant differences
The olfactory bulb is a source of high-frequency oscillations. . .
MJ Hunt et al.
3
Neuropsychopharmacology (2018) 0:1 – 8
across all rats (see Fig. 2c, f which show values for individual rats).
Of note, unilateral infusion of muscimol to the OB reduced, rather
than completely attenuated, the power of ketamine-enhanced
HFO in the VS ipsilateral to the infusion (muscimol × time F56,672
= 5.24, p < 0.0001).
Ketamine-HFO are dependent on naris respiratory input
Given the prominent role that the OB appears to have in the
generation of HFO we next investigated the effect of naris
blockade. These experiments were carried out during recovery
from ketamine anaesthesia where HFO begins to emerge
(Supplementary Figure 2), rather than in anaesthesia where HFO
is absent [8]. At this stage, rats are manageable and short-lasting
naris blockade can be carried out. During unilateral naris blockade
we observed an almost immediate reduction in the HFO power
(repeated-measures one-way ANOVA F= 9.6, p < 0.0024). Reduc-
tion of HFO power in the OB occurred exclusively on the ipsilateral
side and quickly recovered when blockade was removed
(see example trace in Fig. 3a). In contrast, a tendency for an
increase in HFO power was observed on the contralateral side
(repeated-measures one-way ANOVA F= 3.6, p= 0.064). Means
of HFO power before, during and after naris blockade are shown
in Fig. 3b and individual traces showing the power of HFO
from individual rats are also shown. We also analysed the power
of HFO in the VS and found parallel changes (Fig. 3c).
A source of ketamine-HFO lies within the OB
The laminar distribution of HFO in the OB was investigated in
freely moving rats (n= 4, one rat excluded due to electrode
location) chronically implanted with 32-channel linear silicon
probes. Histological examination revealed that the ﬁnal localisa-
tion of the electrodes in three rats spanned the granule cell layer
(GCL), intraplexiform (IPL), mitral (ML) and extraplexiform layer
(EPL) (Fig. 4a). In one rat histology revealed that the ﬁnal
localisation of the probe was the glomerular and olfactory nerve
layer and probe alignment indicated that it did not transect the
ML during descent. Consistent with our previous data, marked
increases in HFO power were observed after injection of ketamine
25mg/kg (Supplementary Figure 3).
Analysis of raw LFP’s revealed HFO phase reversal in the three
rats where the track transected the ML. We observed a gradual
reduction in HFO power moving across the ML (Fig. 4b1). Phase
analysis, using the shallowest electrode as a reference, revealed
HFO sharply shifted in phase at the level of the ML/IPL (Fig. 4b2).
HFO, and the raw LFP remained broadly in phase across all
contacts in the implantation that did not transect the ML (excluded
rat). CSD analysis revealed clear source/sink pairs close to or at the
level of the ML/IPL in the three rats, an example is shown in Fig. 4c
along with the corresponding HFO amplitude. No HFO phase
reversal was visible when all contacts were above the ML, or in the
implantation which did not cross the ML (data not shown).
Fig. 2 Unilateral muscimol inactivation of the OB attenuates HFO power locally and in the VS on the ipsilateral side. a, d LFP spectrograms
showing the effect of pre-infusion of saline (right OB) or muscimol (0.5 µg/0.5 µl) (left OB) on the power of 25mg/kg ketamine-enhanced HFO
recorded locally in the OB and in the VS. Rats were disconnected for infusion and injection, indicated by the blank spectral spaces in the
spectrograms. b, e Examples of 130–180 Hz band-pass ﬁltered signals and corresponding raw LFP after systemic injection of ketamine for
saline (top pair) and muscimol-infused sides (bottom pair). c, f Mean power of HFO recorded in the OB and VS for muscimol (ﬁlled) and saline-
infused sides (open), before and after 25mg/kg ketamine (n= 6 rats, two experiments per rat). Ketamine injection is indicated by the dotted
line. Adjacent plots show the values for individual rats recorded in the OB and VS after muscimol infusion and ketamine (i.p). Note, unilateral
OB-muscimol infusion almost completely attenuated HFO power in the OB, but only partial reduction in power in the VS
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Spiking was observed in the raw recorded potential (insert in
Fig. 4d) which was more pronounced in the IPL/ML and EPL.
Global multi-unit activity (MUA), units > 1.5 SD above the mean,
was calculated for each rat, which marginally correlated with the
negative peak of the ﬁeld ketamine-HFO recorded at the most
distal electrode (Fig. 4e). Isolation of the largest spikes within the
MUA (>3 SD above the mean) revealed a strong correlation with
the negative peak of the ﬁeld HFO recorded at the most distal
electrode (Fig. 4f). Mitral cells in the ML and tufted cells in the EPL
are the principle projection neurons of the OB and thresholded
MUA from these two areas were comparably phase-locked to the
HFO ﬁeld for multiple cycles.
DISCUSSION
The present results reveal a source for ketamine-enhanced HFO in
the OB. This HFO effectively projected to VS and was dependent
on both neuronal activity within OB and normal naris function.
While the precise cellular and network origin of this HFO remains
unresolved, large-amplitude spiking in the ML and EPL—contain-
ing the main projection neurons in OB—was phase locked to the
HFO ﬁeld.
Axons of OB projection neurons (mitral and tufted cells) are
fasciculated and send direct projections to multiple olfactory
and non-olfactory regions [27]. This extensive connectivity, which
also includes the hippocampus via the entorhinal cortex, may
underlie the broad neuroanatomical nature of ketamine-HFO
observed in the rat brain. It has long been established that
normal oscillatory activity in the rodent OB can be entrained by
nasal respiration. For example, air forced in the nostrils of
anesthetised rats can produce membrane ﬂuctuations in the
OB [28] and air-puffs can reinstate slow OB oscillations in
tracheostomised rats [29]. Although we did not measure nasal
air ﬂow, ketamine-induced HFO seem to share similarities. They
were powerfully attenuated by ipsilateral, but not contralateral,
naris blockade. Additionally, HFO recorded after administration
of NMDA receptor antagonists are phase amplitude-coupled
to slower frequencies, typically delta and theta [7, 30] which
tightly align to the so-called 'respiratory rhythm' known to
modulate the amplitude of higher frequency rhythms in the
other brain areas [31]. It is plausible that increased HFO power
in the OB contralateral to naris blockade may be related to
compensatory increased respiratory strength, indicating ketamine-
HFO may be related to air-ﬂow.
Despite strong OB→ VS causality scores, the OB is unlikely to
represent the sole source of HFO along this axis. Certainly, the
short phase offset (around 0.5 ms) between the OB and VS would
rule out volume conduction from OB and render polysynaptic
pathways unlikely. Previously, we have observed a similar delay for
frontal versus NAc recordings [11]. The physiological explanation
for such a short delay (synaptic is typically at least 1 ms) is unclear,
however, 0.5 ms is likely to be a conservative estimate since OB
recordings were obtained from the GCL, where the power of HFO
was larger, rather than the mitral/EPL—the source of the major
outputs. Local circuits in many structures have been shown to
generate HFO [32, 33]. Indeed, reversible inactivation of the NAc (a
subregion of VS) [11] can reduce HFO power locally, and local
NMDAR blockade potentiates HFO power [6, 34]. In this study,
unilateral reversible inhibition of the OB almost completely
attenuated HFO locally, but only reduced HFO power in the VS
on the ipsilateral side and with differing temporal dynamics.
Together, these ﬁndings suggest HFO generators also reside
within, or close to, ventral striatal tissue under the inﬂuence of the
OB generator.
Caution is needed in assigning anatomical sources to LFP
oscillations in small structures in vivo. van der Meer and
colleagues have shown that gamma oscillations recorded in the
VS may arise from volume-conducted signals originating in
the piriform cortex [35]. Further, HFO and gamma do not appear
to have local source-sink pairs in the VS [26, 35], in line with a
more distant source. This lack of deﬁnitive localisation of HFO
within VS may not have overt interpretational consequences in
terms of function though. Although the olfactory tubercle, rather
than the NAc receives OB input [36] both ventral striatal areas
have been shown to work as a single complex in modulating
certain motivational behaviours [37]. In contrast, clear sources
and sinks have been observed for HFO (this study) and gamma
frequencies in OB [38]. Although microinjection of drugs such
as muscimol, used here, may also spread to adjacent structures,
the OB is sufﬁciently anatomically isolated to allow conﬁdence
in local action of perfused drugs, especially given the relatively
small volume of drug infused. However, we cannot exclude
the possibility that large volumes infused to the NAc (see previous
paragraph) may also spread to adjacent areas such as the
piriform cortex and olfactory tubercle. The role these olfactory
regions may play in HFO generation remains to be explored.
Further complexity arises when it is considered that local NMDAR
blockade in the hippocampus, NAc and prefrontal cortex can
Fig. 3 Unilateral naris occlusion reduces HFO power on the ipsilateral side. a LFP spectrograms from the OB recorded simultaneously from the
side ipsilateral (bottom) and contralateral (top) to naris occlusion. b Mean ± SEM power of HFO demonstrating unilateral naris blockade
produces an ipsilateral reduction in HFO power and corresponding increase in HFO power on the contralateral side. The adjacent plot shows
the power of HFO for individual rats recorded from the contralateral (broken lines) and ipsilateral (continuous lines) sides. c Naris occlusion
also reduced the power of HFO in the VS
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also increase the power of HFO locally and in distant areas,
indicating possible multiple interconnecting networks may also
mediate emergence of this oscillation [6], but again these studies
may be confounded by the large volumes and high concentra-
tions of drug used.
Within OB the origin of the HFO remains to be fully resolved.
A number of cell subtypes have been shown to generate
outputs in this frequency range: Periglomerular interneurons
[39], Tufted cells in the EPL [40] and Mitral cells under
strong olfactory drive [41]. The dependence on olfactory input,
shown by naris occlusion here, has previously been shown to
reduce these HFO-frequency neuronal outputs [42]. The network
connectivity needed to locally synchronise such neuronal
outputs to generate the HFO ﬁeld are much less clear. Mitral
cell-mitral cell excitatory and gap-junctional connectivity is
strong but the kinetics of the coupling signals are too slow to
support HFO [43, 44]. Shared inhibition onto mitral cells from
granule and periglomerular cells also appears far too slow
to support HFO, though they can synchronise this cell subtype
[45, 46]. However, the rapid bursts of spikes generated by tufted
cells have been shown to provide very fast excitatory postsynaptic
potentials onto mitral cells [47]. From this we suggest that
interaction between an intrinsic mitral cell time-constant and a
matching input (perhaps from shared tufted cells)—both compa-
tible with the observed population HFO frequency and both
having axons that anatomically converge towards the location of
highest HFO ﬁeld power recorded here (Fig. 4b)—may provide the
most parsimonious putative mechanisms for the phenomenon
observed.
Granule cells, because of their parallel geometry, are likely to
make a major contribution to the LFP signal in the OB [48].
Dendro-dendritic inhibition from granule cells onto mitral cells is
important for the synchronisation of mitral cell ﬁring, observed
here. In turn, granule cells can be driven by excitatory input from
mitral cells and also from the piriform cortex [49]. Although we did
not record any obvious spiking in GCL, fast oscillations in the OB
can be generated through subthreshold activity of granule cells.
Indeed, there is evidence that fast oscillations in the OB, at least
for gamma, do not require somatic ﬁring of granule cells [50].
Further studies, possibly using reversible inhibition and in vivo
intracellular recordings, are warranted to determine the extent
of the neural network underlying HFO after ketamine and the
cellular substrate of this oscillation.
The potentiation of HFO via ketamine may be easier to assign a
mechanism to. Ketamine selectively targets NMDA receptors on
interneurons (NR2A) [51] and thus generates a transient period of
disinhibition. Enhanced excitation in the OB shifts mitral cell
outputs into the HFO range [41]. Evidence for such an enhanced
excitatory drive, via disinhibition, comes from the apparent
reciprocal effects of ketamine of HFO and gamma oscillation
power (e.g. Fig. 1a). The gamma rhythm is dependent on fast
phasic synaptic inhibition [52] and NMDA receptor antagonists
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most dorsal contact were used) c2 CSD analysis of the same data showing HFO dipoles occur close to the ML. d Raw, 130–180 Hz band-pass
ﬁltered, and multi-unit (>500 Hz) recordings from the ML and EPL. Insert, asterisks indicate the spike-associated HFO in raw LFP’s from the ML
and EPL. e, fMean discharge probability of multi-unit activity from ML and EPL layers at (global ﬁring was taken at a threshold of >1.5 SD in (e)
and larger spikes were extracted at a threshold of >3 SD in (f). Spike discharge was triggered on the trough of HFO from the most dorsal
electrode contact (>3 SD). Multi-unit ﬁring tends to occur close to the negative peak of HFO and on the falling phase of the oscillation on a
cycle-by-cycle basis. Values are shown for individual rats (n= 3, colour corresponds to implantations shown in a)
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have previously been shown to attenuate this frequency band in
OB [53] and elsewhere [54].
There is growing evidence for a role for olfaction in psychiatric
illness. Neuronal oscillations in olfactory systems are phylogeneti-
cally conserved across many species [55] and equivalent circuits
are found in humans, sometimes with substantial cross-talk
between traditional olfactory areas and those responsible for
affective processing. In addition to the evidence cited above it is
worth noting that reduced OB volume as well as a shallower
olfactory sulcus [19] has been reported in schizophrenia (and in
patients at risk). Also, olfactory bulbectomy is one of the most
widely employed rodent models of depression [21] and there is
growing interest in intranasal delivery of ketamine for the
treatment of this disease. The clinically relevant effects of
ketamine administered in this way often long outlast the acute
effects of this drug. However, intense (HFO-related) bursts of
output from principal neurons have long been known to
powerfully generate long-term synaptic plasticity [56]. Thus
transient periods of HFO output from OB may induce long-
lasting changes in functional connectivity of wider olfactory,
cognitive and affective pathways in the brain.
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